InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Plasmocure™ - Mycoplasma Elimination Reagent | Confounding off-target effects of BH3 mimetics at commonly used concentration... | 2019 | Cell Death Dis. | Mallick D.J. et al. | DOI: 10.1038/s41419-019-1426-3 |
| Plasmocure™ - Mycoplasma Elimination Reagent | Identification of rigosertib for the treatment of recessive dystrophic epider... | 2019 | Clin Cancer Res. | Atanasova V.S. et al. | DOI: 10.1158/1078-0432.CCR-18-2661 |
| Plasmocure™ - Mycoplasma Elimination Reagent | Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression. | 2017 | Clin Cancer Res. | Lochmann T.L. et al. | DOI: 10.1158/1078-0432.CCR-17-1606 |
| Pam3CSK4 | Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance. | 2019 | Cell | Ganeshan K. et al. | DOI: 10.1016/j.cell.2019.01.050 |
| Poly(I:C) LMW | Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance. | 2019 | Cell | Ganeshan K. et al. | DOI: 10.1016/j.cell.2019.01.050 |
| ODN 1826 - TLR9 ligand | Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance. | 2019 | Cell | Ganeshan K. et al. | DOI: 10.1016/j.cell.2019.01.050 |
| FLA-ST (Standard or Ultrapure) | Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance. | 2019 | Cell | Ganeshan K. et al. | DOI: 10.1016/j.cell.2019.01.050 |
| HKLM | Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance. | 2019 | Cell | Ganeshan K. et al. | DOI: 10.1016/j.cell.2019.01.050 |
| Imiquimod (R837) | Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance. | 2019 | Cell | Ganeshan K. et al. | DOI: 10.1016/j.cell.2019.01.050 |
| LL-37 | LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhib... | 2019 | Antiviral Res. | Brice D.C. et al. | DOI: 10.1016/j.antiviral.2018.07.025 |
| LL-37 | Differential Expression of Antimicrobial Peptides in Streptococcus pneumoniae... | 2019 | Pathogens. | Sharma P. et al. | DOI: 10.3390/pathogens8010031. |
| LL-37 | Comparison of Anti-Viral Activity of Frog Skin Anti-Microbial Peptides Tempor... | 2019 | Viruses | Roy M. et al. | DOI: 10.3390/v11010077. |
| 2'3'-cGAMP | Acetylation Blocks cGAS Activity and Inhibits Self-DNA-Induced Autoimmunity. | 2019 | Cell | Dai J. et al. | DOI: 10.1016/j.cell.2019.01.016 |
| 2'3'-cGAMP VacciGrade™ | Acetylation Blocks cGAS Activity and Inhibits Self-DNA-Induced Autoimmunity. | 2019 | Cell | Dai J. et al. | DOI: 10.1016/j.cell.2019.01.016 |
| c-di-GMP | Acetylation Blocks cGAS Activity and Inhibits Self-DNA-Induced Autoimmunity. | 2019 | Cell | Dai J. et al. | DOI: 10.1016/j.cell.2019.01.016 |
| c-di-GMP VacciGrade™ | Acetylation Blocks cGAS Activity and Inhibits Self-DNA-Induced Autoimmunity. | 2019 | Cell | Dai J. et al. | DOI: 10.1016/j.cell.2019.01.016 |
| LumiKine™ Xpress mIFN-β 2.0 | Innate Immune Signaling Organelles Display Natural and Programmable Signaling... | 2019 | Cell | Tan Y. et al. | DOI: 10.1016/j.cell.2019.01.039 |
| ODN 1826 - TLR9 ligand | Innate Immune Signaling Organelles Display Natural and Programmable Signaling... | 2019 | Cell | Tan Y. et al. | DOI: 10.1016/j.cell.2019.01.039 |
| LumiKine™ Xpress hIFN-β 2.0 | Innate Immune Signaling Organelles Display Natural and Programmable Signaling... | 2019 | Cell | Tan Y. et al. | DOI: 10.1016/j.cell.2019.01.039 |
| Pam2CSK4 | Innate Immune Signaling Organelles Display Natural and Programmable Signaling... | 2019 | Cell | Tan Y. et al. | DOI: 10.1016/j.cell.2019.01.039 |